Invivyd (IVVD) Accounts Payables (2020 - 2025)
Invivyd (IVVD) posted Accounts Payables of $13.7 million for Q4 2025, down 24.08% on a QoQ basis from $18.1 million in Q3 2025, and up 31.55% year-over-year from $10.4 million in Q4 2024.
Invivyd (IVVD) Accounts Payables (2020 - 2025) Analysis & Trends
Invivyd's Accounts Payables history runs 6 years deep, the most recent figure standing at $13.7 million for Q4 2025.
- Quarterly Accounts Payables rose 31.55% year-over-year to $13.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.7 million (up 31.55% YoY) and the FY2025 annual result came in at $13.7 million, up 31.55% from the prior year.
- Accounts Payables was $13.7 million for Q4 2025 at Invivyd, down from $18.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $18.7 million in Q1 2022 and bottomed at $1.2 million in Q1 2024.
- A 5-year average of $10.9 million and a median of $10.4 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables tumbled 80.25% — and 2025, when it jumped 648.2%.
- Invivyd's Accounts Payables stood at $5.8 million in 2021, then tumbled by 73.77% to $1.5 million in 2022, then surged by 424.26% to $8.0 million in 2023, then soared by 31.37% to $10.4 million in 2024, then surged by 31.55% to $13.7 million in 2025.
- Business Quant data shows IVVD's Accounts Payables at $13.7 million in Q4 2025, $18.1 million in Q3 2025, and $18.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 13.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.74 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Jun 30, 2025 | 18.05 Mn |
| Mar 31, 2025 | 8.74 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 16.77 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 18.68 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 17.56 Mn |
| Jun 30, 2021 | 10.72 Mn |
| Dec 31, 2020 | 8.15 Mn |